Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
June 10, 2010
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
K H T Paraiso, I V Fedorenko, L P Cantini, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 31, 2000
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)
D F Smith, J L Messina, R Perrott, et al.
Cancer
|
March 1, 1996
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy
R Heller, M J Jaroszeski, L F Glass, et al.
Annals of Surgical Oncology
|
July 24, 2020
Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
C R Farley, M C Perez, S J Soelling, et al.
Annals of Surgical Oncology
|
February 28, 2020
Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
C R Farley, M C Perez, S J Soelling, et al.
British Journal of Cancer
|
December 1, 2011
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
A P Algazi, J S Weber, S C Andrews, et al.
The Journal of the Florida Medical Association
|
March 1, 1997
The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy
A Brobeil, D Kamath, C W Cruse, et al.
The British Journal of Dermatology
|
July 2, 2015
Genetic variations in the epidermodysplasia verruciformis (EVER/TMC) genes, cutaneous human papillomavirus infection and squamous cell carcinoma of the skin
S S Hampras, D E Rollison, M Tommasino, et al.
The British Journal of Dermatology
|
November 16, 2018
Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation
S S Hampras, M Tommasino, Y Zhao, et al.
Oncogene
|
June 16, 2015
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
I V Fedorenko, E V Abel, J M Koomen, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
June 10, 2010
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
K H T Paraiso, I V Fedorenko, L P Cantini, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 31, 2000
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)
D F Smith, J L Messina, R Perrott, et al.
Cancer
|
March 1, 1996
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy
R Heller, M J Jaroszeski, L F Glass, et al.
Annals of Surgical Oncology
|
July 24, 2020
Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
C R Farley, M C Perez, S J Soelling, et al.
Annals of Surgical Oncology
|
February 28, 2020
Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
C R Farley, M C Perez, S J Soelling, et al.
British Journal of Cancer
|
December 1, 2011
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
A P Algazi, J S Weber, S C Andrews, et al.
The Journal of the Florida Medical Association
|
March 1, 1997
The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy
A Brobeil, D Kamath, C W Cruse, et al.
The British Journal of Dermatology
|
July 2, 2015
Genetic variations in the epidermodysplasia verruciformis (EVER/TMC) genes, cutaneous human papillomavirus infection and squamous cell carcinoma of the skin
S S Hampras, D E Rollison, M Tommasino, et al.
The British Journal of Dermatology
|
November 16, 2018
Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation
S S Hampras, M Tommasino, Y Zhao, et al.
Oncogene
|
June 16, 2015
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
I V Fedorenko, E V Abel, J M Koomen, et al.
Page
of 7